We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience. You can read our Cookie Policy here.
At the British Neuroscience Association's Festival of Neuroscience 2019, Professor John Hardy of University College London explains how knowledge of the role that genetics play in the development of neurodegenerative conditions has been harnessed to develop novel and more successful therapeutics.
